Peak Pharmaceuticals, Inc. (PKPH)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Peak Pharmaceuticals, Inc. (PKPH) with AI Score 46/100 (Weak). Peak Pharmaceuticals, Inc. is a bio-pharmaceutical and nutraceutical company focused on developing, manufacturing, and marketing hemp-based medicinal products. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 18, 2026Peak Pharmaceuticals, Inc. (PKPH) Financial Services Profile
Peak Pharmaceuticals, Inc., operating in the financial services sector as a shell company, focuses on developing and marketing hemp-based medicinal products. The company targets the over-the-counter market with THC-free solutions aimed at inflammatory and auto-immune diseases, distinguishing itself through its specific focus on hemp extracts.
Investment Thesis
Peak Pharmaceuticals, Inc. presents a speculative investment opportunity within the bio-pharmaceutical and nutraceutical sectors. The company's focus on developing THC-free, hemp-based products for inflammatory and auto-immune diseases aligns with growing consumer interest in alternative medicines. However, with a market capitalization of $0.00B and only one employee, the company's operational scale and financial resources are limited. Key value drivers include successful product development and regulatory approval. Growth catalysts depend on market acceptance of hemp-based treatments. Potential risks include competition from established pharmaceutical companies and evolving regulatory landscapes surrounding hemp-derived products. The company's future success hinges on its ability to secure funding, navigate regulatory hurdles, and effectively market its products.
Based on FMP financials and quantitative analysis
Key Highlights
- Peak Pharmaceuticals, Inc. operates in the bio-pharmaceutical and nutraceutical sector, focusing on hemp-based products.
- The company targets the over-the-counter market with THC-free solutions for inflammatory and auto-immune diseases.
- Peak Pharmaceuticals, Inc. was formerly known as Cannabis Therapy Corporation, indicating a shift in focus.
- The company's headquarters are located in Scottsdale, Arizona.
- Peak Pharmaceuticals, Inc. has a market capitalization of $0.00B, reflecting its small size and early stage.
Competitors & Peers
Strengths
- Focus on a growing market segment (hemp-based products).
- THC-free formulations cater to a specific consumer demand.
- Potential for developing proprietary formulations.
- Established presence in the bio-pharmaceutical and nutraceutical sectors.
Weaknesses
- Limited financial resources (market cap of $0.00B).
- Small operational scale (1 employee).
- Dependence on regulatory approvals.
- Limited brand recognition compared to larger competitors.
Catalysts
- Upcoming: Potential regulatory changes in the hemp-based products market could create new opportunities or challenges.
- Ongoing: Increasing consumer demand for natural and alternative medicines.
- Ongoing: Research and development of novel hemp-based formulations.
- Upcoming: Potential partnerships with established pharmaceutical or nutraceutical companies.
- Upcoming: Expansion into new geographic markets.
Risks
- Potential: Competition from larger pharmaceutical and nutraceutical companies.
- Potential: Evolving regulatory landscape for hemp-derived products.
- Potential: Changing consumer perceptions regarding the safety and efficacy of hemp-based treatments.
- Ongoing: Limited financial resources and operational scale.
- Ongoing: Dependence on regulatory approvals.
Growth Opportunities
- Expansion into New Product Lines: Peak Pharmaceuticals can explore developing new hemp-based products targeting different health conditions, such as sleep disorders, anxiety, and pain management. The global market for sleep aids is projected to reach $112.7 billion by 2029, presenting a significant opportunity. Successful product diversification could drive revenue growth and expand the company's market reach. This expansion depends on research and development capabilities and securing necessary regulatory approvals.
- Strategic Partnerships and Collaborations: Peak Pharmaceuticals can pursue strategic partnerships with established pharmaceutical companies or nutraceutical distributors to leverage their expertise and distribution networks. Collaborating with research institutions can also accelerate product development and validation. These partnerships could provide access to funding, resources, and market channels, enhancing the company's competitive position and growth prospects. The timeline for establishing such partnerships is dependent on negotiation and due diligence processes.
- Direct-to-Consumer Sales Channels: Establishing a direct-to-consumer (DTC) sales channel through an e-commerce platform can enable Peak Pharmaceuticals to reach a wider customer base and improve profit margins. The global e-commerce market is expected to reach $7.4 trillion in 2025, indicating a significant opportunity for online sales. This strategy requires investment in digital marketing, customer service, and logistics infrastructure. The timeline for launching a DTC channel depends on website development, marketing campaign execution, and supply chain optimization.
- Geographic Expansion: Peak Pharmaceuticals can expand its operations into new geographic markets, both domestically and internationally, to tap into untapped demand for hemp-based products. The global nutraceuticals market is projected to reach $578.23 billion by 2025. Entering new markets requires adapting products to local regulations and consumer preferences. This expansion strategy involves market research, regulatory compliance, and establishing distribution networks. The timeline for geographic expansion depends on regulatory approvals and market entry strategies.
- Research and Development of Novel Formulations: Investing in research and development to create novel formulations and delivery methods for hemp-based products can provide a competitive advantage. Developing innovative products with enhanced efficacy and bioavailability can attract customers and differentiate Peak Pharmaceuticals from competitors. This strategy requires significant investment in scientific research, clinical trials, and intellectual property protection. The timeline for developing and commercializing novel formulations depends on research outcomes and regulatory approval processes.
Opportunities
- Expansion into new product lines and geographic markets.
- Strategic partnerships with established companies.
- Direct-to-consumer sales channels.
- Increasing consumer awareness of hemp-based products.
Threats
- Competition from larger pharmaceutical and nutraceutical companies.
- Evolving regulatory landscape for hemp-derived products.
- Changing consumer perceptions regarding the safety and efficacy of hemp-based treatments.
- Potential for supply chain disruptions.
Competitive Advantages
- Focus on THC-free hemp-based products.
- Proprietary formulations and manufacturing processes.
- Brand recognition in the hemp-based products market.
About PKPH
Peak Pharmaceuticals, Inc., established in 2007 and based in Scottsdale, Arizona, operates as a bio-pharmaceutical and nutraceutical company. Originally incorporated as Cannabis Therapy Corporation, the company rebranded in December 2014 to reflect its broader focus on medicinal products derived from hemp extracts. Peak Pharmaceuticals is involved in the development, manufacture, marketing, and sale of over-the-counter, THC-free, hemp-based products. These products are intended for the human market, specifically targeting the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company's strategy centers around leveraging the potential therapeutic benefits of hemp extracts to address prevalent health conditions. Peak Pharmaceuticals aims to establish a market presence in the nutraceutical and pharmaceutical sectors by providing accessible and effective hemp-based solutions. The company's operations are primarily based in the United States.
What They Do
- Develop over-the-counter, THC-free, hemp-based products.
- Manufacture medicinal products based on extracts from hemp.
- Market hemp-based products for human consumption.
- Sell products for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases.
- Operate as a bio-pharmaceutical company.
- Operate as a nutraceutical company.
Business Model
- Develop and manufacture hemp-based medicinal products.
- Market and sell products directly to consumers or through distributors.
- Generate revenue through product sales.
Industry Context
Peak Pharmaceuticals, Inc. operates within the evolving bio-pharmaceutical and nutraceutical industry, specifically targeting the hemp-based products market. This market is characterized by increasing consumer interest in natural remedies and alternative medicines. The competitive landscape includes established pharmaceutical companies, as well as smaller firms specializing in hemp-derived products. Peak Pharmaceuticals aims to differentiate itself by focusing on THC-free formulations and targeting specific health conditions. The industry is subject to regulatory changes and evolving consumer perceptions regarding the safety and efficacy of hemp-based treatments.
Key Customers
- Individuals seeking over-the-counter treatments for inflammatory and auto-immune diseases.
- Consumers interested in natural and alternative medicines.
- Retailers and distributors of nutraceutical and pharmaceutical products.
Financials
Chart & Info
Peak Pharmaceuticals, Inc. (PKPH) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
-
Stocks That Hit 52-Week Lows On Tuesday
· Oct 15, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PKPH.
Price Targets
Wall Street price target analysis for PKPH.
MoonshotScore
What does this score mean?
The MoonshotScore rates PKPH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Shell CompaniesLeadership: Jerry Swon
CEO
Jerry Swon is the CEO of Peak Pharmaceuticals, Inc. His background includes managing small teams and overseeing the strategic direction of the company. He has experience in the bio-pharmaceutical and nutraceutical sectors, with a focus on developing and marketing hemp-based products. His leadership is focused on driving innovation and growth within the company. He is responsible for the overall management and performance of Peak Pharmaceuticals, Inc.
Track Record: Under Jerry Swon's leadership, Peak Pharmaceuticals, Inc. has focused on developing over-the-counter, THC-free, hemp-based products. He has overseen the company's efforts to target the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. Key milestones include the rebranding from Cannabis Therapy Corporation to Peak Pharmaceuticals, Inc. in 2014.
PKPH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Peak Pharmaceuticals, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Limited regulatory oversight.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price activity.
- Consult with a financial advisor.
- Company has been in operation since 2007.
- Focus on a specific market segment (hemp-based products).
- Development of over-the-counter products.
- Company has a CEO.
- Company has a physical headquarters.
What Investors Ask About Peak Pharmaceuticals, Inc. (PKPH)
What does Peak Pharmaceuticals, Inc. do?
Peak Pharmaceuticals, Inc. is a bio-pharmaceutical and nutraceutical company that develops, manufactures, markets, and sells medicinal products based on extracts from hemp. The company focuses on creating over-the-counter, THC-free products for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. These products are intended for the human market, providing accessible and effective hemp-based solutions. The company aims to establish a market presence in the nutraceutical and pharmaceutical sectors by leveraging the therapeutic benefits of hemp extracts.
What do analysts say about PKPH stock?
AI analysis is currently pending for Peak Pharmaceuticals, Inc. Therefore, a summary of analyst consensus, key valuation metrics, and growth considerations is unavailable at this time. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions regarding PKPH stock. Further information will be needed to assess the company's financial performance, growth prospects, and potential risks.
What are the main risks for PKPH?
Peak Pharmaceuticals, Inc. faces several risks, including competition from larger pharmaceutical and nutraceutical companies with greater resources and established market presence. The evolving regulatory landscape for hemp-derived products poses a risk, as changes in regulations could impact the company's ability to market and sell its products. Changing consumer perceptions regarding the safety and efficacy of hemp-based treatments could also affect demand. Additionally, the company's limited financial resources and operational scale present challenges to its growth and sustainability.
How does Peak Pharmaceuticals, Inc. manage regulatory compliance?
As a bio-pharmaceutical and nutraceutical company focusing on hemp-based products, Peak Pharmaceuticals, Inc. must navigate a complex and evolving regulatory landscape. The company needs to comply with regulations related to the cultivation, processing, manufacturing, and marketing of hemp-derived products. This includes adhering to labeling requirements, quality control standards, and restrictions on THC content. The company's ability to effectively manage regulatory compliance is crucial for maintaining its operations and avoiding potential penalties or legal issues. The costs associated with compliance can also impact profitability.
How sensitive is PKPH to changes in consumer preferences?
Peak Pharmaceuticals, Inc. is highly sensitive to changes in consumer preferences, as its success depends on the demand for hemp-based products. Shifts in consumer perceptions regarding the safety, efficacy, and desirability of hemp-derived treatments can significantly impact the company's sales and market share. The company needs to closely monitor consumer trends and adapt its product offerings and marketing strategies to meet evolving preferences. Negative publicity or concerns about the quality or safety of hemp-based products could negatively affect consumer demand and the company's financial performance.
What are the key factors to evaluate for PKPH?
Peak Pharmaceuticals, Inc. (PKPH) currently holds an AI score of 46/100, indicating low score. Key strength: Focus on a growing market segment (hemp-based products).. Primary risk to monitor: Potential: Competition from larger pharmaceutical and nutraceutical companies.. This is not financial advice.
How frequently does PKPH data refresh on this page?
PKPH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven PKPH's recent stock price performance?
Recent price movement in Peak Pharmaceuticals, Inc. (PKPH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Focus on a growing market segment (hemp-based products).. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on OTC-traded companies.
- AI analysis pending, limiting comprehensive insights.